Fox Chase Cancer Center News

PHILADELPHIA (July 18, 2024) — Teh Lin, PhD, DABR, FAAPM, an Associate Professor in Fox Chase Cancer Center’s Department of Radiation Oncology, has been named a Fellow of the American Association of Physicists in Medicine (AAPM).

PHILADELPHIA (July 17, 2024) — Lauren Farnon, MSHS, disease site research manager for the Thoracic Cancer Program and the Head and Neck Cancer Program research teams, has been selected as a member of the ECOG-ACRIN Clinical Research Associates Core Committee.

PHILADELPHIA (July 16, 2024) — Fox Chase Cancer Center has earned national rankings of 33 in cancer and 19 in urology among the country’s top 50 hospitals in the 2024-2025 Best Hospitals rankings from U.S. News & World Report.

PHILADELPHIA (July 16, 2024) — The African American/Black community is at increased risk for morbidity and mortality from smoking-related diseases, including lung cancer, but unfortunately, when it comes to diagnosis and treatment, smoking stigma is believed to be a primary barrier to healthcare for this community.

PHILADELPHIA (July 12, 2024) — Fox Chase Cancer Center and the Lewis Katz School of Medicine at Temple University are pleased to announce the hiring of Akina Tamaki, MD, FACS, as an Associate Professor in the Department of Otolaryngology – Head and Neck Surgery at the Katz School of Medicine.

PHILADELPHIA (July 11, 2024) — Three Fox Chase Cancer Center researchers have received a grant totaling nearly $2.4 million from the Leukemia & Lymphoma Society (LLS) to study racial and ethnic equity in clinical trials.

PHILADELPHIA (July 2, 2024) — Fox Chase Cancer Center is pleased to announce the hiring of J. Ryan Mark, MD, FACS, as an Associate Professor in the Department of Urology and the Fox Chase – Temple Urologic Institute.

PHILADELPHIA (June 14, 2024) — Researchers have developed a multicellular model of a pancreatic cancer tumor mass using human cells. The model uses bioprinting, which combines bioinks/biomaterials and two types of cells, to recreate the complex structure that makes pancreatic cancers among the most difficult to treat.